The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2009
DOI: 10.1159/000325401
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic Utility of MOC-31, HBME-1 and MOC-31mRNA in Distinguishing Between Carcinoma Cells and Reactive Mesothelial Cells in Pleural Effusions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
18
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 20 publications
(21 citation statements)
references
References 17 publications
2
18
1
Order By: Relevance
“…The current study included a wide variety of primary sites of metastatic adenocarcinoma, including 1 case originating in the thyroid and 1 case originating in the kidney, which to our knowledge had not been included in the studies by Morgan et al 1 or Hecht et al 19 The current series also included effusions from various body cavities, whereas the series by Sun et al focused on pleural effusions only. 20 The results of the current study found minimal and focal cytoplasmic staining in 13% of cases with reactive mesothelial cells/mesothelioma; however, we did not observe the characteristic membranous staining in these cases that is noted in adenocarcinoma. Hecht et al described positive staining for MOC-31 in scattered mesothelial cells in 9 of their 112 cases.…”
Section: -18contrasting
confidence: 88%
See 2 more Smart Citations
“…The current study included a wide variety of primary sites of metastatic adenocarcinoma, including 1 case originating in the thyroid and 1 case originating in the kidney, which to our knowledge had not been included in the studies by Morgan et al 1 or Hecht et al 19 The current series also included effusions from various body cavities, whereas the series by Sun et al focused on pleural effusions only. 20 The results of the current study found minimal and focal cytoplasmic staining in 13% of cases with reactive mesothelial cells/mesothelioma; however, we did not observe the characteristic membranous staining in these cases that is noted in adenocarcinoma. Hecht et al described positive staining for MOC-31 in scattered mesothelial cells in 9 of their 112 cases.…”
Section: -18contrasting
confidence: 88%
“…Sun et al reported a sensitivity of 70% and 100% specificity in pleural effusions. 20 The results of the current study also demonstrated a high sensitivity of MOC-31 of 89% and specificity of 100%. The current study included a wide variety of primary sites of metastatic adenocarcinoma, including 1 case originating in the thyroid and 1 case originating in the kidney, which to our knowledge had not been included in the studies by Morgan et al 1 or Hecht et al 19 The current series also included effusions from various body cavities, whereas the series by Sun et al focused on pleural effusions only.…”
Section: -18supporting
confidence: 68%
See 1 more Smart Citation
“…So far, many tumor markers directed against specific cell type antigens have been used in pleural effusions to enhance the cytological diagnosis, with varying degrees of efficacy [7, 8], but the optimum panel of tumor markers still has to be reported. Moreover, the definition of earlier diagnosis of pleural effusions of patients with lung cancer by means of detecting tumor marker mRNA in occult lung cancer cells had previously been reported in our studies [9, 10]. …”
Section: Introductionmentioning
confidence: 60%
“…Therefore, there is a need for a more accurate method of detecting malignant cells. Recently, we have evaluated RT-PCR techniques for the detection of cancer cells in pleural effusions of patients with lung cancer, and have demonstrated that these techniques are more sensitive than immunocytochemistry [16,17]. RT-PCR can objectively detect even 1 cancer cell among 10 6 cells [18,19].…”
Section: Discussionmentioning
confidence: 99%